Kura Oncology (KURA) Accumulated Depreciation (2014 - 2026)

Kura Oncology (KURA) has 13 years of Accumulated Depreciation data on file, last reported at $3.2 million in Q1 2026.

• Accumulated Depreciation for Q1 2026 came in at $3.2 million, down 7.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (down 7.82% YoY), and the FY2025 annual result was $2.9 million, down 11.45% from the prior year.
• Accumulated Depreciation advanced to $3.2 million in Q1 2026 per KURA's latest filing, from $2.9 million in the prior quarter.
• Over five years, Accumulated Depreciation peaked at $3.9 million in Q3 2025 and troughed at $1.0 million in Q1 2022.
• A 5-year average of $2.5 million and a median of $2.7 million in 2024 frame the typical range for Accumulated Depreciation.
• The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation jumped 159.14% in 2022, then declined 11.45% in 2025.
• A 5-year view of Accumulated Depreciation shows it stood at $1.6 million in 2022, then surged by 52.96% to $2.5 million in 2023, then surged by 33.56% to $3.3 million in 2024, then slipped by 11.45% to $2.9 million in 2025, then grew by 11.76% to $3.2 million in 2026.
• Business Quant data shows KURA's Accumulated Depreciation at $3.2 million in Q1 2026, $2.9 million in Q4 2025, and $3.9 million in Q3 2025.